Rikhsieva , O. .; Rajabova , N. HIGH-COST ANTICANCER DRUGS: CLINICAL BENEFIT OR FINANCIAL BURDEN FOR THE HEALTHCARE SYSTEM?. EJAR 2025, 5, 197.